Locations:

Tag: ASCO17

June 5, 2017/Cancer/Research

Time to Treat is Increasing, Associated with Worsened Survival

Cleveland Clinic study of 3.7 million patients

June 5, 2017/Cancer/Research

Study Suggests Some Small Cell Lung Cancer Patients Benefit from Immune Checkpoint Inhibitor

Pembrolizumab stabilizes cancer in some patients

June 5, 2017/Cancer/Research

Trial Finds Maximum Tolerable Dose for Combination Therapy for Metastatic Renal Cell Carcinoma Patients

Axitinib and crizotinib stabilized disease in most

June 4, 2017/Cancer/Research

Maximum Tolerable Doses for Adding Cell Checkpoint Inhibitor to Standard of Care for Glioblastoma Patients

Inhibitor stops DNA repair of cancer cells

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

June 3, 2017/Cancer/Research

A Novel Approach: Aggressive Chemotherapy Regimen Before Surgery in Resectable Pancreatic Adenocarcinoma

May increase some pancreatic cancer survival rates

May 29, 2017/Cancer/News & Insight

ASCO 2017 – Friday, June 2

Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASCO Annual Meeting

BackPage 1 of 1Next